Astria Therapeutics Inc. (ATXS)
7.46
-0.03 (-0.40%)
At close: Jan 29, 2025, 3:59 PM
7.46
0.07%
After-hours Jan 29, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -72.89M | -51.83M | -194.91M | -37.30M | -26.29M | -25.87M | -27.36M | -36.06M | -32.63M | -21.88M | -18.12M | -15.67K |
| Depreciation & Amortization | n/a | n/a | n/a | n/a | 26.00K | 119.00K | 304.00K | 395.00K | 202.00K | 248.00K | 320.00K | 327.00 |
| Stock-Based Compensation | 6.31M | 4.55M | 3.36M | 1.39M | 1.51M | 1.77M | 2.01M | 2.16M | 1.66M | 897.00K | 343.00K | 196.00 |
| Other Working Capital | -3.14M | 3.41M | -1.34M | 3.02M | -1.66M | 100.00K | -1.30M | 197.00K | 488.00K | -228.00K | 1.22M | n/a |
| Other Non-Cash Items | 545.00K | 1.10M | 164.70M | 58.00K | 33.00K | 56.00K | 155.00K | 277.00K | 293.00K | 74.00K | 343.00K | -241 |
| Deferred Income Tax | n/a | n/a | n/a | n/a | 23.00K | -303.00K | -4.00K | 96.00K | n/a | n/a | -343.00K | n/a |
| Change in Working Capital | -2.41M | 2.65M | -3.31M | 3.37M | -1.87M | 762.00K | -1.93M | 274.00K | 684.00K | 253.00K | 1.09M | n/a |
| Operating Cash Flow | -68.44M | -43.53M | -30.15M | -32.48M | -26.57M | -23.46M | -26.84M | -32.86M | -29.79M | -20.41M | -16.37M | -15.58K |
| Capital Expenditures | -25.00K | -91.00K | -21.00K | -33.00K | -12.00K | 18.00K | -57.00K | -459.00K | -421.00K | -228.00K | -43.00K | -360 |
| Acquisitions | n/a | 167.04K | 6.47M | -6.33K | 4.07K | -18.00K | 45.54M | 52.00K | n/a | n/a | n/a | n/a |
| Purchase of Investments | -1.92B | -396.06M | -78.00M | -62.78M | -155.20M | -70.36M | -45.54M | -45.54M | n/a | -4.98M | n/a | n/a |
| Sales Maturities Of Investments | 2.06B | 229.03M | 59.00M | 69.11M | 151.13M | 48.09M | 14.91M | 30.46M | n/a | 4.98M | n/a | n/a |
| Other Investing Acitivies | n/a | -167.04K | -12.53K | 6.33K | -4.07K | 369.00K | 30.00K | 52.00K | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 135.05M | -167.13M | -12.55M | 6.30M | -4.08M | -21.91M | 14.88M | -15.49M | -421.00K | -228.00K | -43.00K | -360 |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | -2.85M | -3.33M | -3.33M | 4.17M | 5.00M | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 420.00K | 84.00K | 23.00K | 31.00K | 54.00K | 4.00K | 23.00K | 503.00K | 12.41M | -166.00K | 41.45M | n/a |
| Financial Cash Flow | 88.40M | 144.72M | 104.28M | 40.86M | 25.62M | 44.30M | 4.73M | 9.16M | 78.33M | 4.83M | 41.45M | 8.75K |
| Net Cash Flow | 155.00M | -65.94M | 61.58M | 14.68M | -5.03M | -1.07M | -7.23M | -39.18M | 48.11M | -15.81M | 25.04M | -7.20K |
| Free Cash Flow | -68.47M | -43.62M | -30.17M | -32.52M | -26.58M | -23.45M | -26.89M | -33.32M | -30.21M | -20.64M | -16.41M | -15.94K |